Susquehanna International Group, LLP Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$13.28 - $15.96 $57,104 - $68,628	-4,300 Reduced 21.18%	16,000 $225,000
Q1 2023 May 16, 2023	SELL	$14.26 - $22.1 $1.01 Million - $1.57 Million	-71,000 Reduced 77.77%	20,300 $313,000
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $164,835 - $211,344	-11,100 Reduced 10.84%	91,300 $1.5 Million
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $397,398 - $649,383	-32,100 Reduced 23.87%	102,400 $1.89 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $295,164 - $452,952	32,400 Added 31.73%	134,500 $1.77 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $2.21 Million - $3.58 Million	-322,200 Reduced 75.94%	102,100 $946,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $2.85 Million - $13.7 Million	369,700 Added 677.11%	424,300 $4.15 Million
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $664,146 - $932,465	25,100 Added 85.08%	54,600 $1.86 Million
Q2 2021 Aug 11, 2021	SELL	$32.73 - $47.95 $160,376 - $234,955	-4,900 Reduced 14.24%	29,500 $1.08 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $407,939 - $572,973	10,100 Added 41.56%	34,400 $1.54 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $1.98 Million - $2.53 Million	-38,300 Reduced 61.18%	24,300 $1.39 Million
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $976,739 - $1.3 Million	-22,300 Reduced 26.27%	62,600 $3.21 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $1.95 Million - $3.43 Million	52,700 Added 163.66%	84,900 $5.07 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $2.3 Million - $4.75 Million	-68,500 Reduced 68.02%	32,200 $1.33 Million
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $1.2 Million - $2.65 Million	37,900 Added 60.35%	100,700 $6.27 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $564,585 - $1.1 Million	28,300 Added 82.03%	62,800 $2.13 Million
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $726,225 - $904,245	34,500 New	34,500 $778,000
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $239,539 - $342,780	-11,600 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $64,871 - $122,876	3,400 Added 41.46%	11,600 $243,000
Q3 2018 Nov 14, 2018	BUY	$33.57 - $42.1 $275,274 - $345,220	8,200 New	8,200 $318,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account